Re: Goldberg et al.: A phase 3, randomized, double-masked study of OTX-101 ophthalmic solution 0.09% in the treatment of dry eye disease (Ophthalmology. 2019;126:1230-1237)

scientific article published on 01 July 2020

Re: Goldberg et al.: A phase 3, randomized, double-masked study of OTX-101 ophthalmic solution 0.09% in the treatment of dry eye disease (Ophthalmology. 2019;126:1230-1237) is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.OPHTHA.2020.01.047
P698PubMed publication ID32564819

P2093author name stringMumta Kanda
Victoria Nowak
P433issue7
P921main subjecteye diseaseQ3041498
P304page(s)e43
P577publication date2020-07-01
P1433published inOphthalmologyQ7098109
P1476titleRe: Goldberg et al.: A phase 3, randomized, double-masked study of OTX-101 ophthalmic solution 0.09% in the treatment of dry eye disease (Ophthalmology. 2019;126:1230-1237)
P478volume127

Search more.